Literature DB >> 372096

Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future.

J B Robbins.   

Abstract

Mesh:

Substances:

Year:  1978        PMID: 372096     DOI: 10.1016/0161-5890(78)90117-7

Source DB:  PubMed          Journal:  Immunochemistry        ISSN: 0019-2791


× No keyword cloud information.
  40 in total

1.  Mutant bacteriophage with non-catalytic endosialidase binds to both bacterial and eukaryotic polysialic acid and can be used as probe for its detection.

Authors:  J Aalto; S Pelkonen; H Kalimo; J Finne
Journal:  Glycoconj J       Date:  2001-10       Impact factor: 2.916

2.  Application of optical properties of the Vi capsular polysaccharide for quantitation of the Vi antigen in vaccines for typhoid fever.

Authors:  A L Stone; S C Szu
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

Review 3.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

4.  Immunogenic properties of Klebsiella pneumoniae type 2 capsular polysaccharide.

Authors:  A Robert; H Jouin; J M Fournier
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

Review 5.  Current status--meningococcal vaccine.

Authors:  R Merchant; R Divekar
Journal:  Indian J Pediatr       Date:  1988 Mar-Apr       Impact factor: 1.967

6.  Development of serum antibodies of the immunoglobulin G class and subclasses against the capsular polysaccharide of Haemophilus influenzae type b in children and adults with invasive infections.

Authors:  B A Claesson; T Lagergård; B Trollfors
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

7.  Studies on immunity against Escherichia coli K13 with monoclonal anti-K13 and anti-anti-K13.

Authors:  T Söderström; L Ohman; K Stein; R Schneerson; W F Vann; L A Hanson
Journal:  Infection       Date:  1984 Jul-Aug       Impact factor: 3.553

8.  Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals.

Authors:  S C Szu; A L Stone; J D Robbins; R Schneerson; J B Robbins
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

9.  Purification and partial characterization of the capsular polymer of Haemophilus pleuropneumoniae serotype 5.

Authors:  T J Inzana
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

10.  Bacterial meningitis in Egypt: analysis of CSF isolates from hospital patients in Cairo, 1977-78.

Authors:  N Guirguis; K Hafez; M A El Kholy; J B Robbins; E C Gotschlich
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.